Loading…
Company: AseBio clear filter
arrow_back View All Dates
Tuesday, September 29
 

16:00 CEST

Engineering the Materials of Life
Tuesday September 29, 2026 16:00 - 16:45 CEST
Engineered living materials (ELMs) are composed, either entirely or partly, of living cells. ELMs entirely composed of living cells are called biological ELMs and they self-assemble via a bottom-up process – e.g. synthetic morphogenesis for organoids’ production. ELMs only partly composed of living cells are called hybrid living materials (HLMs) and are built with a top-down process with integrated polymers or scaffolds. In both cases, the cellular components extract energy from the environment to form or assemble the material itself, and to adapt its morphology and function to environmental stimuli. This endows these materials with a combination of properties not present in any non-living material: self-regeneration, adaptation to environmental clues, longevity and environmental sustainability. By being alive, ELMs represent a fundamental change in materials’ production and performance, enabling new, better or similar functionalities, compared to traditional materials but with decreased costs and environmental impact. ELMs have the potential to transform virtually every modern endeavour from healthcare to infrastructures to transportation.

Representante de Cocoon?
Representante de Regemat3D?
Representante de BASF
Speakers
avatar for Manuel Salmeron Sanchez

Manuel Salmeron Sanchez

ICREA Research Professor / IBEC Director, IBEC (Institute for Bioengineering of Catalonia)
Manuel Salmerón-Sánchez es Profesor de Investigación ICREA y Director interino del Instituto de Bioingeniería de Cataluña (IBEC), cargo que asumió en enero de 2026. Es bioingeniero experto en biomateriales avanzados para ingeniería celular y medicina regenerativa.
Cargo act... Read More →
Tuesday September 29, 2026 16:00 - 16:45 CEST
3 Nicolás Achúcarro room

16:45 CEST

Biotech Act: Accelerating Biotech Scale-Up and Building Competitive Value Chains in Europe
Tuesday September 29, 2026 16:45 - 17:30 CEST
Following the publication of the proposed Biotech Act I Regulation, the European Commission has launched a consultation process for the future Biotech Act II, which will focus on industrial policy and on building a broad, forward-looking biotechnology ecosystem.
In this session, organised by AseBio, we will examine the opportunities presented by Biotech Act II to advance biomanufacturing and biotechnology innovation in Europe, while also addressing the regulatory, financing, and scale-up challenges facing the sector.

Estado ponentes: 
Moderador: Ion Arocena, General Director of AseBio
Miguel Ángel Pavón, Directorate-General for Industrial Strategy and Small and Medium-sized Enterprises (SMEs), Ministry of Industry and Turism – mandada invitación
  • Mrs Kristin Schreiber, Director Chemicals, Bioeconomy and Retail, DG GROW.F, European Commission – mandada invitación
  • Joerg Lindemann - MD / Site Manager WACKER
  • Ana Maria Bravo-Angel, Director of Public Affairs at IFF - mandada invitación


Tuesday September 29, 2026 16:45 - 17:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date -